VIVIMED LABS LTD.
BSE: 532660
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 18.66+4.0% | 17.94-20.5% | 22.57-34.1% | 34.23+54.5% | 22.16 |
| Other Income | 0.16-55.6% | 0.36-91.3% | 4.15+138300.0% | 0.00-88.9% | 0.03 |
| Total Income | 18.82+2.8% | 18.30-31.5% | 26.73-21.9% | 34.24+54.3% | 22.19 |
| EXPENSES | |||||
| Expenditure | 26.26+10.4% | 23.80-22.1% | 30.56-25.8% | 41.21+51.6% | 27.18 |
| Tax | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | |||||
| PBT | -7.45-35.5% | -5.50-43.2% | -3.84+45.0% | -6.97-39.7% | -4.99 |
| Net Profit | -7.45-35.5% | -5.50-43.2% | -3.84+45.0% | -6.97-39.7% | -4.99 |
| KEY METRICS | |||||
| OPM % | -7.07%-4.08pp | -2.99%+5.44pp | -8.43%+31.81pp | -40.24%+1.52pp | -41.76% |
| NPM % | -39.56%-9.54pp | -30.02%-15.66pp | -14.36%+6.01pp | -20.37%+2.13pp | -22.50% |
| EPS | 0.90+36.4% | 0.66+128.6% | -2.31-175.0% | -0.84-40.0% | -0.60 |
Corporate Events
Board MeetingVIVIMEDLAB
202628May
Board Meeting
The board meeting is scheduled to consider and approve audit…
BSE Filing ↗ Board MeetingVIVIMEDLAB
202613Mar
Board Meeting
To consider and approve un-audited Financial Results (Standa…
BSE Filing ↗ Board MeetingVIVIMEDLAB
202513Nov
Board Meeting
Consider and approve Notice of Board Meeting, consider and a…
BSE Filing ↗ Board MeetingVIVIMEDLAB
202530May
Board Meeting
Consider and approve Notice of Board Meeting / Closure, cons…
BSE Filing ↗ Board MeetingVIVIMEDLAB
202414Nov
Board Meeting
audited Financial Results (Standalone & Consolidated) of the…
BSE Filing ↗ Board MeetingVIVIMEDLAB
20246Sep
Board Meeting
audited Financial Results (Standalone & Consolidated) of the…
BSE Filing ↗ Board MeetingVIVIMEDLAB
202420May
Board Meeting
Consider and approve audited Financial Results (Standalone &…
BSE Filing ↗